Review article · 2026 · Open access

Best practices for the collection and analysis of patient experience data from social media for patient-focused drug development

Philipp Cimiano, Nicole Brazda, Matthias Härtung, Cornelius Starke-Knäusel, Ana Lucia Schmidt, Maria Carmela De Vuono, Aditya S. Tyagi, Juergen Gottowik, Raul Rodriguez‐Esteban, Ben Collins, Krzysztof Wieckowski, Thierry Escudier

Frontiers in Medicine, 12, 1703923 · Published 30 January 2026 · DOI 10.3389/fmed.2025.1703923

Open PDFView at the publisherCite this paper

In brief

“Best practices for the collection and analysis of patient experience data from social media for patient-focused drug development” is a 2026 review article by Philipp Cimiano and 11 co-authors, published in Frontiers in Medicine. OpenAlex counts 4 citations as of 22 November 2026, which puts it in the top 4% of works published in 2026 by citations. It is open access under a CC BY licence: the full text is free to read at Frontiers in Medicine.

Citations
4
Most cited in
2026 (4)
Field-weighted impact
3.76
References
93
Authors
12

Abstract

Patient experience data derived from social media captures the unsolicited conversations of patients and helps in understanding their subjective experiences with disease and treatments. By comparison, many other real-world datasets, such as electronic health records, have the drawback that they solely capture the perspective of health care practitioners. Regulators such as the FDA or EMA have recognized the potential of social media as a source of patient experience data that can inform patient-focused drug development. While social media has limitations, such as the reliance on patient or caregiver self-reporting, it allows us to understand the subjective perception and context of patients, how they experience their condition, its progression, existing treatments and how they manage these, which unmet needs they have, and how the disease affects their daily lives and activities. All this is crucial information that can inform drug development initiatives, and help substantiate relevant outcomes measured, both in clinical trials as well as in post-marketing evidence generation activities. This paper proposes best practices for Social Media Listening (SML) for the purpose of Real World Evidence generation along the following dimensions: purposes and objectives of a SML study, data collection, and data analysis. To illustrate how these best practices can be adopted, we showcase their application in a case study, aiming to unveil the key symptoms and comorbidities that diabetes type II patients face and how these affect their quality of life across an observation period of 24 months. We believe the proposed best practices will contribute to provide a rigorous methodological ground for the use of social media in generating patient experience data that can inform patient-focused drug development and could be accepted in regulatory processes.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Cimiano, P., Brazda, N., Härtung, M., Starke-Knäusel, C., Schmidt, A. L., De Vuono, M. C., Tyagi, A. S., Gottowik, J., Rodriguez‐Esteban, R., Collins, B., Wieckowski, K., & Escudier, T. (2026). Best practices for the collection and analysis of patient experience data from social media for patient-focused drug development. Frontiers in Medicine, 12, 1703923. https://doi.org/10.3389/fmed.2025.1703923

MLA 9

Cimiano, Philipp, et al. “Best practices for the collection and analysis of patient experience data from social media for patient-focused drug development.” Frontiers in Medicine, vol. 12, 2026, p. 1703923. https://doi.org/10.3389/fmed.2025.1703923.

Chicago

Cimiano, Philipp, Nicole Brazda, Matthias Härtung, Cornelius Starke-Knäusel, Ana Lucia Schmidt, Maria Carmela De Vuono, Aditya S. Tyagi, et al. 2026. “Best practices for the collection and analysis of patient experience data from social media for patient-focused drug development.” Frontiers in Medicine 12: 1703923. https://doi.org/10.3389/fmed.2025.1703923.

Harvard

Cimiano, P. et al. (2026) ‘Best practices for the collection and analysis of patient experience data from social media for patient-focused drug development’, Frontiers in Medicine, 12, p. 1703923. doi:10.3389/fmed.2025.1703923.

IEEE

P. Cimiano et al., “Best practices for the collection and analysis of patient experience data from social media for patient-focused drug development,” Frontiers in Medicine, vol. 12, p. 1703923, 2026, doi: 10.3389/fmed.2025.1703923.

BibTeX

@article{cimiano2026best,
  title     = {{Best practices for the collection and analysis of patient experience data from social media for patient-focused drug development}},
  author    = {Cimiano, Philipp and Brazda, Nicole and Härtung, Matthias and Starke-Knäusel, Cornelius and Schmidt, Ana Lucia and De Vuono, Maria Carmela and Tyagi, Aditya S. and Gottowik, Juergen and Rodriguez‐Esteban, Raul and Collins, Ben and Wieckowski, Krzysztof and Escudier, Thierry},
  journal   = {Frontiers in Medicine},
  year      = {2026},
  volume    = {12},
  pages     = {1703923},
  doi       = {10.3389/fmed.2025.1703923},
  url       = {https://doi.org/10.3389/fmed.2025.1703923}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Social Sciences › Social Sciences › Health › Social Media in Health Education

  • social media monitoring
  • patient experience data
  • patient-focused drug development
  • real-world evidence
  • best practices
  • type 2 diabetes
  • quality of life
  • comorbidities

Work with this paper

Most-cited papers in Social Sciences

All highly cited Social Sciences papers

Questions about this paper

How do I cite this paper in APA style?

Cimiano, P., Brazda, N., Härtung, M., Starke-Knäusel, C., Schmidt, A. L., De Vuono, M. C., Tyagi, A. S., Gottowik, J., Rodriguez‐Esteban, R., Collins, B., Wieckowski, K., & Escudier, T. (2026). Best practices for the collection and analysis of patient experience data from social media for patient-focused drug development. Frontiers in Medicine, 12, 1703923. https://doi.org/10.3389/fmed.2025.1703923

How many times has this paper been cited?

4 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Frontiers in Medicine: sign in and open the PDF from this page.

Who wrote this paper?

Philipp Cimiano, Nicole Brazda, Matthias Härtung, Cornelius Starke-Knäusel, Ana Lucia Schmidt, Maria Carmela De Vuono, Aditya S. Tyagi, Juergen Gottowik, Raul Rodriguez‐Esteban, Ben Collins, Krzysztof Wieckowski, Thierry Escudier.

What is the DOI of this paper?

10.3389/fmed.2025.1703923, permanently at https://doi.org/10.3389/fmed.2025.1703923. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.